Gladius Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.4M |
| 2 |
Microsoft
MSFT
|
+$11.9M |
| 3 |
Amazon
AMZN
|
+$8.93M |
| 4 |
Tesla
TSLA
|
+$5M |
| 5 |
AbbVie
ABBV
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$6.18M |
| 2 |
Meta Platforms (Facebook)
META
|
+$4.93M |
| 3 |
NVIDIA
NVDA
|
+$3.82M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.81M |
| 5 |
Oracle
ORCL
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.56% |
| 2 | Consumer Discretionary | 1.01% |
| 3 | Communication Services | 0.3% |
| 4 | Consumer Staples | 0.25% |
| 5 | Healthcare | 0.16% |
Similar funds
Gladius Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Gladius Capital Management held 119 positions worth $1.82B, up 93% from $944M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Gladius Capital Management deployed $848M of net new capital in Q4 2025, opening 17 new positions and adding to 76 existing holdings. Its largest new stake was AbbVie: 7,572 shares worth $1.73M.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 2.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was NVIDIA, an estimated $3.82M trimmed.
- Gladius Capital Management's largest Q4 2025 buy was AbbVie: 7,572 shares worth $1.73M.
- Gladius Capital Management added most to Apple in Q4 2025, an estimated $17.4M increase.
- Gladius Capital Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.82M.
- Gladius Capital Management fully exited Broadcom in Q4 2025, selling an estimated $6.18M.
- Gladius Capital Management's ten largest holdings make up 49% of its $1.82B portfolio in Q4 2025.
- Gladius Capital Management opened 17 new positions and closed 18 in Q4 2025.
- Gladius Capital Management's portfolio value rose 93% quarter-over-quarter to $1.82B.
Based on Gladius Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.